Patents
Patents for C07K 19 - Hybrid peptides (29,428)
05/2005
05/04/2005CN1612895A Conjugates comprising an antibody specific for the ED-B domain of fibronectin and their use for the detection and treatment of tumours
05/04/2005CN1612890A Novel chimeric tnf ligands
05/04/2005CN1612750A TACI-immunoglobulin fusion proteins
05/03/2005US6887847 Virus derived antimicrobial peptides
05/03/2005US6887670 For drug screening; solid phase synthesis; fusion proteins; genetic engineering
05/03/2005US6887659 A quantitative analyzing the concentration of peptide with monoclonal antibody produced by the fused cell hybrid; medical diagnosis
05/03/2005US6887472 That do not cause anaphylaxis, antigenic fusion proteins of given amino acid sequence, of a CH3 domain of an immunoglobulin (IgE) molecule; allergy vaccines; vaccine test methods in dogs
05/03/2005US6887470 Covalently bonding albumin to oligopeptide; biochemical conjugation; analyzing stability
05/03/2005CA2147623C Novel p-selectin ligand protein
04/2005
04/28/2005WO2003095971A3 Posh nucleic acids, polypeptides and related methods
04/28/2005US20050091702 Expression of polypeptides in rod outer segment membranes
04/28/2005US20050090461 Synthesizing polyketide fusion protein comprising acyltransferase domain for use as anthelminthic, insecticide, antitumor, immunosuppressant, fungicidal and/or bactericidal agents
04/28/2005US20050089970 Polymer-modified bioactive synthetic chemokines, and methods for their manufacture and use
04/28/2005US20050089957 Chimera; immunoglobuins; antibodies; host cells; immunohistochemistry
04/28/2005US20050089933 Compositions and methods for surrogate antibody modulation of an immune response and transport
04/28/2005US20050089841 Induction of a Th1-like response in vitro
04/28/2005CA2543406A1 Mutants of human chondromodulin-i (hchm-i) and uses thereof in inhibiting angiogenesis and bone resorption
04/28/2005CA2536082A1 Therapeutic uses of chemokine variants
04/27/2005EP1526183A2 Dimer of a peptide derived from the C-terminal sequence of human superoxide dismutase facilitating the penetration of a substance into cells and/or cell nuclei
04/27/2005EP1526141A2 MHC complexes and uses thereof
04/27/2005EP1524994A1 Vaccine compositions containing amyloid beta1-6 antigen arrays
04/27/2005EP1423527A4 System for detecting protease
04/27/2005EP1150707B1 USE OF AN OmpA ENTEROBACTERIUM PROTEIN ASSOCIATED WITH THE ELAGIGILTV PEPTIDE FOR TREATING MELANOMAS
04/27/2005EP0939818B1 Recombinant toxin fragments
04/27/2005CN1610737A Phenotypic screen of chimeric proteins
04/27/2005CN1610695A Human monoclonal antibodies to epidermal growth factor receptor (EGFR)
04/27/2005CN1610556A Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen
04/27/2005CN1609222A Alkaline phosphatase gene and its coding protein and application
04/27/2005CN1609124A Calreticulin-tumor necrosis factor correlated apoptosis inducing ligand fusion protein and its prepn and use
04/27/2005CN1198936C Alzheimer's disease secretase
04/26/2005US6884620 Genetic engineering
04/26/2005US6884618 Identification of the gene causing the mouse scurfy phenotype and its human ortholog
04/26/2005US6884574 Methods of identifying agents which inhibit GPR-9-6
04/26/2005US6884431 Method for treating proliferative diseases with p27 and fusions thereof
04/26/2005CA2253871C Ret ligand (retl) for stimulating neural and renal growth
04/21/2005WO2005035585A1 Support having affinity for antibody
04/21/2005CA2542860A1 Fluorescence indicator utilizing fret
04/21/2005CA2542046A1 Fused protein composition
04/20/2005EP1523558A1 Production of peptides and proteins by accumulation in plant endoplasmic reticulum-derived protein bodies
04/20/2005EP1523336A1 Targeted agents for nerve regeneration
04/20/2005EP0871704B1 Transcriptional co-repressor that interacts with nuclear hormone receptors and uses therefor
04/20/2005EP0759995B1 Fusion glycoprotein from hcmv and hsv
04/20/2005CN1608129A Alkaline protease from bacillus sp. (DSM 14392) and washing and cleaning products comprising said alkaline protease
04/20/2005CN1197877C AsLc-IFN fusion protein and its preparation
04/20/2005CN1197876C Chimeric protein containing an intramolecular chaperone-like sequence and its application to insulin production
04/19/2005US6881832 Comprises nucleotide sequences coding signal sequences for transport of heterologous proteins into preferential cellular compartments
04/19/2005US6881821 Hepatitis-C virus type 4, 5, and 6
04/19/2005US6881577 DNA-peptide-lipid complex for enhancing gene transfer into cells; cationic liposomes
04/19/2005US6881564 Enzymatic peptide comprising modified asparaginic residues for treatment of tumors, infection, liver and autoimmune disorders
04/14/2005WO2005033147A1 Interacting polypeptide comprising a heptapeptide pattern and a cellular penetration domain
04/14/2005WO2005032496A2 Hydrolases, nucleic acids encoding them and mehods for making and using them
04/14/2005WO2005002512A3 Immunotherapeutic vaccine strategy
04/14/2005WO2004096989A3 Single chain antigen-binding polypeptides for polymer conjugation
04/14/2005WO2004092215A3 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin-2
04/14/2005WO2004031105A3 Use of a33 antigens and jam-it
04/14/2005US20050080237 Oligomeric molecules and uses thereof
04/14/2005US20050080233 Expression vector comprising nucleotide sequences coding bacterial outer membrane protein for use in diagnosis, prevention and treatment of microorganismal infection
04/14/2005US20050080014 Thrombopoietic compounds
04/14/2005US20050079541 Immunoadhesin comprising a glycorprotein v1 domain
04/14/2005US20050079538 polynucleotides which identify and encode human secreted proteins (SECP); expression vectors, host cells, antibodies, agonists, and antagonists; drug screening; anticarcinogenic agents
04/14/2005CA2541015A1 Igf binding proteins
04/14/2005CA2540520A1 Interacting polypeptide comprising a heptapeptide pattern and a cellular penetration domain
04/14/2005CA2524209A1 Antiviral agents for the treatment, control and prevention of infections by coronaviruses
04/14/2005CA2515583A1 Hydrolases, nucleic acids encoding them and methods for making and using them
04/13/2005EP1522591A2 Transgenically produced non-secreted proteins
04/13/2005EP1521968A1 Secreted polypeptide species associated with cardiovascular disorders
04/13/2005EP1521824A2 Nucleic acid-associated proteins
04/13/2005EP1521775A1 Monoclonal antibody pam4 and its use for diagnosis and therapy of pancreatic cancer
04/13/2005EP1478747A4 Method for making purified plasminogen activator-inhibitor type 1 (pai-1) and purified pai-1 made therefrom
04/13/2005EP1465912A4 Novel chimeric tnf ligands
04/13/2005EP1356075A4 Protein scaffolds for antibody mimics and other binding proteins
04/13/2005EP1183353B1 Modified chimeric polypeptides with improved pharmacokinetic properties
04/13/2005CN1606626A Novel alkaline protease from bacillius sp. (DSM 14390) and washing and cleaning products comprising said novel alkaline protease
04/13/2005CN1606619A Novel alkaline protease from bacillus gibsonii (DSM 14391) and washing and cleaning agents containing said novel alkaline protease
04/13/2005CN1606618A Novel alkali protease formed by bacillus gibsonii (DSM 14393) and washing and cleaning agents containing said novel alkali protease
04/13/2005CN1606570A A fusion protein suitable to highly effective expression and production method thereof
04/13/2005CN1606453A Cripto blocking antibodies and uses thereof
04/13/2005CN1196791C Psudomonas exotoxin-myelin basic protein chimeric proteins
04/13/2005CN1196788C Assembly of wild-type and chimeric influenza virus-like particles (VLPS)
04/13/2005CN1196785C Beta-amyloid peptdie-binding proteins and polynucleotides encoding the same
04/13/2005CN1196495C Mutant human CD80 and compositions and methods of making and using the same
04/12/2005US6878376 Modulate immunology response
04/12/2005CA2417135C Chimeric pre-activated transcription factors
04/12/2005CA2123363C Lysosomal enzyme-cleavable antitumor drug conjugates
04/12/2005CA2113813C Immunoglobulin variants for specific fc epsilon receptors
04/12/2005CA2074825C Chimeric chains for receptor-associated signal transduction pathways
04/07/2005WO2002066615A3 Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system
04/07/2005US20050076395 Transgenic mouse comprising nucleotide sequences coding immunoglobulin domains j, c, v and d for use as bioreactor in biosynthesis of human antibodies; immunodiagnostics
04/07/2005US20050074839 Novel survivin interacting protein tpr1
04/07/2005US20050074797 FHIT proteins and nucleic acids and methods based thereon
04/07/2005US20050074427 IL-17 like molecules and uses thereof
04/07/2005US20050074426 A conjugate of a cytokine and a tumor targeting moiety with numerous provisos
04/06/2005EP1520019A2 Adapter-directed display system
04/06/2005EP1519950A2 Components of the presenilin-complex
04/06/2005EP1284997B1 Therapeutic compounds for ovarian cancer
04/06/2005EP1117769B1 Cloning and recombinant production of polistinae venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon
04/06/2005EP1002093B1 Preparation and use of recombinant influenza a virus m2 constructs and vaccines
04/06/2005EP0553244B2 Targeted immunostimulation with bispecific reagents
04/06/2005CN1604966A Direct targeting binding proteins
04/06/2005CN1604965A 生长激素融合蛋白 Growth hormone fusion protein